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Abstract
Background: Cancer survivors are a rapidly growing and aging population in the U.S., but there are many
challenges associated with the survivorship experience such as functional disabilities and psychosocial distress.
When viewed next to the general population, Veterans are especially at risk for these challenges as they are older
and have a high incidence of co-morbid conditions. While the Institute of Medicine (IOM) has called for further
cancer survivorship research to address these challenges, we still know little about this experience from the
perspective of aging Veterans.
Methods/design: We conducted a longitudinal, mixed-methods study over the course of three and a half years at
the Boston and Houston VA Medical Centers. We recruited 170 Veterans diagnosed with head and neck, colorectal
and esophageal/gastric cancers that were identified from the VA tumor registry. Veterans completed three in-depth
interviews, conducted at 6, 12 and 18 months after pathology confirmation, measuring the physical, social and
psychological factors related to cancer survivorship. The longitudinal design allowed us to assess any changes in
cancer related disability and distress over time.
Discussion: Weekly teleconference study team meetings were a key aspect to the research process. Issues related
to recruitment, data management and analysis, and the dissemination of research results was discussed.
Interviewers presented detailed case reports of completed interviews that allowed us to refine our interview
protocols. We also discussed issues relevant to the Veteran population of which we were previously unaware and
some of the challenges of the research process itself. This novel study produced a robust data set that documents
the functional and psychosocial cancer survivorship experiences of aging Veterans. The longitudinal design will help
us more fully understand the recovery patterns for this specific population, and identify the unique needs and gaps
in health services.
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Background
Cancer survivorship has steadily increased in prevalence
since the mid-1970s [1-3] and currently there are over 13
million survivors in the United States alone [3,4]. The
number of cancer survivors – defined as “any person who
has been diagnosed with cancer, from the time of
diagnosis through the balance of life” [2] – is likely to in-
crease by 5 million over the next 10 years [3]. Cancer sur-
vivors are a rapidly growing and aging population [3], but
the survivorship experience is frequently a double-edged
sword. Pain, psychosocial distress and the onset of func-
tional disabilities are long-term costs that cancer survivors
often must face as they move forward with their lives [5].
Cancer type and stage, psychosocial stresses and sup-
ports, co-morbidities, and diverse treatment protocols
make survivorship a variable experience [6,7]. Adults age
40 and over comprise the majority of cancer survivors in
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is over the age of 65 [3,5]. Consequently, age is one such
factor that complicates survivorship. The long-term ef-
fects of cancer treatment can hasten and/or worsen
chronic co-morbid conditions (e.g. diabetes) and func-
tional declines that are part of the normal aging process
[8-13]. Viewed next to the U.S. population, Veterans of
the U.S. military are at an especially high risk for these
consequences as they are typically older, have higher
rates of co-morbid conditions and may also have combat
related post-traumatic stress disorder (PTSD), all factors
complicating their survivorship experience [14-17].
The Institute of Medicine’s (IOM) influential report
From Cancer Patient to Cancer Survivor: Lost in Transi-
tion [5] draws attention to these long-term physical and
psychosocial effects of cancer treatment, and calls for re-
search to improve and implement appropriate survivor-
ship care. Survivorship research has grown over the
years in response to the IOM’s call [18], yet we still
know very little about cancer survivorship from the per-
spective of aging Veterans [17]. Therefore, the goal of
this study is to recognize the functional and psychosocial
effects of cancer diagnosis and treatment from diagnosis
to 18 months for aging Veterans diagnosed with head
and neck, colorectal, and esophageal/gastric cancers,
and to identify the unique survivorship needs of this
population. Results from this study will help us more
fully understand the recovery patterns for aging Veteran
cancer survivors and identify potential areas for sur-
vivorship interventions.
Specific aims & hypotheses
Aim 1 & hypotheses
To determine the longitudinal course of functional disabil-
ity and psychological distress. We hypothesized significant
distress and disability at 6 months, with improvement in a
portion over 18 months, will be predicted by disease stage
and treatments, age, social support, and mental health
history.
Aim 2 & hypotheses
To determine the impact of disability and distress on
community integration. We hypothesized reintegration to
community roles will be predicted by distress and func-
tional disability, as moderated by the use of rehabilitative
interventions and reports of post-traumatic growth.
Aim 3 & hypotheses
To characterize gaps in Veterans Health Administration
(VHA) rehabilitative services for Veterans following can-
cer. We hypothesized high levels of overall satisfaction
with Veterans Affairs (VA) medical care, with reports of
lower satisfaction in emotional support and education,
and moderate obstacles to receiving rehabilitative care.
Further, we hypothesized moderate interest in receiving
interventions (e.g. physical rehabilitation, mental health,
complementary medicine and educational services), as
moderated by levels of distress and disability.
Aim 4 & hypotheses
To characterize patient-centered goals for rehabilitation,
community integration, and cancer survivorship treatment
planning for Veterans following cancer. We hypothesized
that this study will reveal previously unknown rehabilita-
tion, community integration and cancer survivorship needs
among this Veteran population.
Methods/design
Design overview
To address these aims, we conducted a longitudinal,
mixed methods study over a three and a half year period
(November 2009-April 2013). Veterans completed in-
depth interviews comprised of closed-ended survey re-
sponses and open-ended short answer questions that mea-
sured a wide variety of physical, social and psychological
factors related to cancer survivorship. These interviews
took place 6 (Time 1), 12 (Time 2) and 18 (Time 3)
months (+/− 4 weeks for each time point) after pathology
analysis confirmed malignancy. We chose to conduct three
interviews in order to measure any change in cancer re-
lated functional disability and distress that occurred during
the study period. Interviews were conducted in-person, or
in rare cases, over the phone (n=7) and lasted approxi-
mately two hours each. Veterans received compensation
for their time after the completion of each interview ($30
per interview). This study received approval in August
2009 from the Boston VA and the Houston VA Institu-
tional Review Boards (IRB) (Houston IRB# 25446; Boston
IRB# 2317). Veterans completed a written consent form
prior to beginning the study, which was entered into the
VA Computerized Patient Records System (CPRS) and be-
came part of the patient’s permanent medical records.
Screening & recruitment
After receiving a Health Insurance Portability and Ac-
countability Act (HIPAA) waiver, we obtained lists of pa-
tients from the VA tumor registry whose diagnosis fell
one month prior to the study’s opening eligibility win-
dow (6 months) (See Figure 1: Screening & Recruitment
Process). Patients were eligible to be interviewed if their
diagnosis fell within this window, and had a diagnosis of
head and neck, esophageal, gastric, or colorectal cancer
(see Additional file 1: International Statistical Classifica-
tion of Diseases and Related Health Problems (ICD-9)
Codes for Cancers included in the study). We utilized
CPRS to screen patients to confirm diagnosis and to ver-
ify that the patient had been informed by their primary
care physician or specialist of their diagnosis. We
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interviewed (patients diagnosed with Dementia or Psych-
otic Disorders on the basis of a medical record review),
and patients receiving hospice care, considered “actively
dying” or with a diagnosis of a pre-cancerous (in-situ) le-
sion. Eligible patients were entered into the study’s recruit-
ment database. Prior to contacting eligible patients, our
Boston site was required to obtain permission from the
patient’s primary care physician or oncologist.
Eligible patients were initially contacted via mail with a
letter inviting them to participate in this study. This letter
described the study’s purpose to learn more about
Veterans’ cancer diagnostic and treatment experiences,
explained that participation was completely voluntary and
confidential, and that choosing to participate will not im-
pact any present or future health care the Veterans receive
through the VA. This letter also outlined the $30 compen-
sation for the Time 1 interview, the interview location as
well as the length of time for the interview. Eligible
patients were informed that if they chose to participate, all
study data was confidential and no identifying information
would be revealed. A phone number was provided for fur-
ther information. Five to seven days post-mailing, eligible
patients were phoned by study coordinators. The purpose
of this phone call was to confirm interest to participate, to
provide further project information, to answer any ques-
tions the Veterans may have, and to schedule a time with
the Veteran for written consent and the Time 1 interview.
Veterans were contacted again at Time 2 (12 months)
and Time 3 (18 months) with follow-up reminder letters
informing them that study coordinators will be in contact
to schedule or confirm their interview. Letters also in-
formed the Veterans that they will be asked some of the
same questions from the Time 1 interview, and some new
questions. Also, Veterans were reminded that they would
receive compensation for completion of each of these sub-
sequent interviews ($30 each), and were provided a phone
number to call if they had any questions.
To account for Veterans who passed away or opted out
of the study after completion of their Time 1 (6 month)
interview, recruitment procedures were amended after the
study began to enroll replacement patients on an as
needed basis. These replacement subjects (n=2) were
expected to complete a Time 2 (12 month) and Time 3
(18 month) interview and received compensation accord-
ingly ($30 per interview). TheTime 2 interview (12 month)
utilized many of the same survey instruments as the Time
1 interview, as well as collected a significant amount of
new data providing study investigators the rationale to re-
cruit these replacements. Replacements were drawn from
those contacted for a Time 1 interview, but were unable to
participate at 6 months due to the severity of their illness
or if confirmation of their malignancy exceeded the initial
24 week criterion. New patients were also recruited at 12 -
months and underwent the same screening process
outlined above.
Participants
A total of 170 Veterans were recruited for the baseline
sample of our study (see Table 1: Demographic Character-
istics of Baseline Time 1 Sample). Just over half of our
sample (53.5%) was younger than age 65 while 46.5% was
age 65 and older. The majority of this sample was male
(98.2%) and almost 20% non-white. Nearly half (49.4%)
had a high school education or less and 50.6% had
attended college or earned a graduate degree. Most
Veterans were diagnosed with either head and neck
(40.0%) or colorectal (49.4%) cancers, with a smaller pro-
portion diagnosed with esophageal/gastric cancers
(10.6%). Using the American Joint Committee on Cancer’s
(AJCC) tumor staging classifications, 23.7% of our sample
was diagnosed at Stage I, 28.4% at Stage II, 21.9% at Stage
III, and 26% at Stage IV. Nearly three quarters of our base-
line sample (72.9%) had surgery and over half were treated
* Includes participants who dropped out at a later date
VA Tumor Registry 
List Obtained
CPRS Screening to 
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Figure 1 Screening & recruitment process. Overview of study
screening and recruitment process arriving at Time 1
(6 month) sample.
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diation therapy (41.1%). Most participants received a com-
bination of two or more therapies.
Methods
To measure longitudinal changes in Veterans functional
disability and distress, the study’s three interview protocols
utilized a diverse array of both quantitative and qualitative
measures (see Table 2: Overview of Key Interview Mea-
sures). We selected these measures with both standardized
and novel elements to provide a comprehensive assess-
ment of the physical and psychosocial impact of cancer
upon Veterans’ lives over time. Interviewers reviewed the
following with Veterans prior to conducting these
interviews: general length of the interview (approximately
2 hours), scheduled breaks during the interview session
(with the option for additional breaks as needed), options
to complete the interview if the participant was unable to
during their scheduled session, and an overview of the
types of questions that will be asked (e.g. standardized
scales). Individual measures for each interview protocol
will be briefly described below.
Time 1 interview (6 months)
The interview measures are presented in Table 2. The
Time 1 (and 3) interview began with physical and cogni-
tive performance screening measures. Veterans were
asked, in general, if their memory, walking or balance, and
body strength was worse, the same or better since their
cancer diagnosis. Following these preliminary questions,
interviewers performed the Montreal Cognitive Assess-
ment (MoCA) [19] that assessed the Veterans’ visual con-
structional skills (e.g. ability to draw a picture), naming
abilities (i.e. ability to name an object), memory, attention
skills (e.g. ability to perform basic subtraction), sentence
repetition, verbal fluency, abstraction (e.g. how two differ-
ent objects are alike), delayed recall (e.g. repeating a list of
words that were provided earlier in the interview) and
orientation (e.g. knowing the current date and interview
location). The Short Physical Performance Battery (SPPB)
[20] assessed balance by having, for example, Veterans
maintain standing poses for ten seconds with their feet
placed in various positions (e.g. side-by-side and tandem)
as well as strength by having Veterans attempt to stand up
and sit down from a chair unassisted (e.g. repeated chair
stand test). We also recorded Veterans gait speed as well
as grip (i.e. hand) strength as part of our physical assess-
ment measures.
Veterans’ background information was collected at Time
1, including demographic factors (age, race/ethnicity, educa-
tion, and preferred language) as well as a brief history of
substance abuse and mental health. Military-related, post-
traumatic stress disorder (PTSD) was measured with the Pri-
mary Care PTSD (PC-PTSD) [21] screen that is used within
the VHA to evaluate the presence or absence of combat-
related PTSD. Open-ended questions were also asked of
Veterans that further explored the relationship between
cancer-related trauma and military post-traumatic stress.
Veterans’ illness narratives (i.e. “Cancer Story”)w e r e
elicited through a series of open-ended questions designed
to document their diagnostic story. We asked participants
“I would like to know the story of your diagnosis. What
I mean is what caused you to be evaluated? How did you
learn about the diagnosis?” Then we asked, “What
was most stressful about the diagnostic experience?”
Additional scripted prompts were used as necessary to
elicit detailed information and responses were recorded
verbatim. Additionally, a series of closed-ended questions
based on the DSM-IV Criterion A1 and A2 PTSD [22]
assessments followed this illness narrative and measured
Veterans’ feelings about death, fear, helplessness and
Table 1 Demographic characteristics of baseline time 1
sample
Characteristic N=170 (%)
Age
<65 91 (53.5)
65-74 50 (30.0)
75-84 24 (14.1)
85+ 4 (2.4)
Sex
Male 165 (98.2)
Female 3 (1.8)
Race/Ethnicity
White 137 (81.2)
Non-white 32 (18.8)
Education
High school or less 83 (49.4)
College/Graduate degree 86 (50.6)
Cancer Type
Head and neck 68 (40.0)
Colorectal 84 (49.4)
Esophageal/Gastric 17 (10.6)
Tumor stage
1 40 (23.7)
2 48 (28.4)
3 37 (21.9)
4 44 (26)
Treatment received*
Surgery 124 (72.9)
Chemotherapy 102 (60.6)
Radiation 71 (41.1)
*Most participants received more than one treatment type.
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physical body. Types of treatments Veterans received (e.g.
surgery, radiation, chemotherapy), their understanding of
the cancer prognosis (e.g. active cancer, relapse, remission,
cure, not sure, or other), and Veterans own and/or family
history of cancer were also documented.
The emotional and physical effects of cancer were
assessed through several measures. We chose to evaluate
cancer-related PTSD symptoms using the PTSD Checklist-
Civilian version (PCL-C) [23] to identify if at any
time during the past four weeks Veterans may have experi-
enced post-traumatic responses (e.g. repeated disturbing
memories or dreams, avoidance, emotional numbness, or
hyper-arousal) when thinking about their diagnostic and
treatment experiences. Respondents were cued to consider
specifically their cancer experiences in rating the PCL
items. Additionally, the Cancer Related Worries Scale [24]
evaluated Veterans’ level of cancer related worry in five do-
mains: fear of recurrence, healthcare, family, existential,
and recovery they may have experienced over the four
weeks prior to this interview. To assess depression, we uti-
lized the nine item Patient Health Questionnaire (PHQ-9)
[25] that corresponds directly to the DSM criteria for
major depression.
Quality of life was measured using the 29-item Patient
Reported Outcomes Measurement Information System
(PROMIS) [26] scale by examining Veterans’ physical
function as well as levels of anxiety, depression, fatigue,
sleep disturbance, sleep quality, ability to meet their social
roles (e.g. work), and how much pain impacts their daily
life and activities. An additional quality of life issue that
arose several months after the study began involved many
Veterans reporting their struggles with prophylactic dental
extraction (e.g. in the case of oral cancers) and denture re-
placement. In response, we added supplementary ques-
tions to the interview protocol to more fully capture
dental care concerns. Immediately following these ques-
tions, the European Organization for Research and Treat-
ment of Cancer Quality of Life Questionnaire (EORTC
QLQ) was included (questionnaires were tailored for the
cancers included in this study: EORTC QLQ-CR29 [27]
for colorectal, OE18 [28] for esophageal, and the H&N35
[29] for head and neck). These questionnaires evaluated
the impact of cancer related symptoms (e.g. hair loss, pain,
dry mouth, weight) experienced by Veterans in the week
prior to their interview.
To address our interest in Veterans’ efforts to re-
integrate back into their communities after cancer (i.e.
re-engage with their social roles and activities held prior
to cancer diagnosis), the Participation Assessment with
Recombined Tools (PART) [6] questionnaire measured
the level of importance particular roles and activities had
Table 2 Overview of key interview measures
Measures Qualitative Quantitative T1: 6-month T2: 12-month T3: 18- month
Adapted Illness Intrusive Ratings Scale (IIRS) x x x
Alcohol Usage (AUDIT) x x
Benefit Finding Scale x x x x
Cancer Related Worry x x x x
Cancer-Related PTSD Symptoms (PCL-C) x x x x
Clinical Impressions (Interviewer Reflections) x x x x
Community Integration (PART) x x x
Depression Assessment (PHQ 9) x x x x
Diagnosis and Treatment Experiences (Cancer Story) x x x x x
Grip strength x x x
Health literacy x x
Health values & goals x x x
Meaning making x x x x x
Military Related PTSD (PC-PTSD) x x x
Montreal Cognitive Assessment (MoCA) x x x
Previous Mental Health and Substance Abuse x x
Quality of Life Assessment (PROMIS 29) x x x x
Sexual Functioning (Treatment Impact Scale) x x x
Short Physical Performance Battery (SPPB) x x x
Site Specific Quality of Life (EORTC QLQ) x x x x
Tobacco usage x x
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tionships with family and friends, religion, recreation
and leisure). Veterans rated these roles and activities
from a level of low, medium or high life importance. Fol-
lowing these ratings, we asked Veterans to determine
how much life satisfaction their medium to high level of
importance activities had from a scale of 0 (total dissatis-
faction) to 10 (high satisfaction). An additional measure,
the adapted Illness Intrusive Ratings Scale (IIRS) [30],
was utilized to measure the level of interference a cancer
diagnosis brought to Veterans’ lives. Veterans were
asked whether a series of pre-determined activities and
feelings were hindered by the effects of their cancer (e.g.
does cancer affect what I can eat, my hobbies, finances,
religious participation, sexual life, relationships and self-
improvement efforts). If cancer did cause interference
with these activities and feelings, Veterans were then
asked to rate this level of interference from 1 to 7, with
7 being the highest level of interference cancer brought
to their lives.
We were also interested in measuring any positive out-
come Veterans may have taken from their cancer experi-
ence and therefore employed the Benefit Finding Scale
(BFS) [31] to evaluate post-traumatic growth. Veterans
assessed how well their personality reflected a set of 22
characteristics (e.g. eating healthfully, exercise, concern
for others, and coping well with stress), and whether
they felt these characteristics had changed since experi-
encing cancer. For example, a participant may not have
had a healthy diet prior to their cancer diagnosis, but
improved their eating habits post-diagnosis. Given that
sexual functioning is often impacted by cancer treat-
ment, we utilized the Treatment Impact Scale [32] that
measured whether Veterans’ physical abilities to perform
and psychological interest in sex were affected by their
cancer diagnosis and treatment, and to what level at
Time 1 and 3. Veterans were reassured of their confi-
dentiality in responding to these questions before inter-
viewers administered this scale given the potential
sensitive nature of this topic, and also had the option of
completing these questions in private. Lastly, to address
our interest in improving cancer survivorship health ser-
vices for Veterans, we concluded the Time 1 interview
with one final open ended question, “What one thing
could the VA do better to support your cancer care
needs?” to elicit ideas from Veterans on this topic.
Time 2 interview (12 months)
The Time 2 interview began by asking Veterans for an
update on their illness narratives with the open-ended
question, “What is happening with your cancer now?”
This question provided the Veterans an opportunity to
report any updates on their treatment experiences since
their previous interview. We followed this question by
asking Veterans if they were currently in treatment, a date
when their treatment ended (if it had), and reassessed can-
cer prognosis by inquiring how the Veterans conceptual-
ized their current cancer status (e.g. active cancer, relapse,
remission, cure, not sure and other). We also asked Vet-
erans to reflect openly on what they found to be most
stressful about their cancer treatment with the following
question: “Looking back at your cancer treatment, what
was most stressful?”
To address gaps in cancer health related services, Vet-
erans were asked a series of closed-ended questions
designed to measure their level of satisfaction with the
VA health care system (e.g. medical care provided, edu-
cation about their treatment, and social support). We
also assessed various kinds of health care obstacles the
Veterans may have faced while undergoing cancer treat-
ment such as financial and/or transportation barriers,
and social barriers such as fear and embarrassment. Vet-
erans’ present and future healthcare needs were evalu-
ated through the use of a pre-determined list of cancer
care needs compiled by the American Society of Clinical
Oncology (ASCO) (prevention and wellness, genetic risk,
emotional or mental health, personal relationships, fertil-
ity, and financial advice or assistance). We shared this
list with Veterans and asked them to respond with either
a yes (I have a need for this), no (I do not have a need
for this), or maybe to these various items. Veterans were
then asked openly to provide any additional cancer sur-
vivorship needs not covered by the ASCO list.
To identify additional health care needs for cancer survi-
vors, Veterans were provided a list of commonly used sur-
vivorship services (educational workshops, computer/
Internet searches, online support groups, physical and oc-
cupational therapy, exercise, diet/supplements, journaling,
meditation, yoga, massage, chiropractic care, acupuncture,
psychotherapy, support groups, and anti-anxiety medica-
tion). We asked the Veterans to identify if they have ever
used these services, or if they have not, if they cannot lo-
cate or are simply not interested in these particular ser-
vices. To evaluate interest level among Veterans in using
yoga to mediate some of their physical and psychological
effects of cancer, we asked if they would come to a VA
sponsored yoga class. If so, we asked Veterans to rate
the likelihood they would find taking a yoga class
embarrassing, whether they felt they were physically able
to take yoga, and whether they felt learning yoga would
benefit their overall health. These additional questions
about yoga were added because of the reported health
benefits of yoga for cancer survivors [33], in the context of
a separate randomized trial of yoga being conducted.
To determine the impact of cancer on Veterans’ social
lives and support systems, we asked Veterans if they
have someone (e.g. spouse, confidant) they can turn to
for emotional and instrumental support. We then had
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(extremely) how their social relationships with family and/
or friends have been impacted by their diagnosis (e.g. can-
cer straining these relationships, self-isolation from family/
friends). These items were developed based on a pilot
study [34].
At the Time 2 interview we were interested in Vet-
erans’ abilities to make meaning from and to cope with
cancer. Therefore we expanded our exploration of this
realm by developing a series of questions based on the
meaning making [35] and religion and spirituality in
medical illness literatures [36-42]. We utilized a series of
open-ended questions designed to elicit Veterans’ per-
ceptions about the meaning of life and death since being
diagnosed with cancer, as well as quantitative ratings
about meaning making processes (see Additional file 2:
Meaning Making: Time 2 Interview). We assessed the
role of lifespan development [43] through the use of two
open ended questions (“What qualities within yourself
helped you most in coping with cancer?” and “Are there
any qualities within yourself that made it harder to cope
with cancer?”) as well as asking Veterans to rate if spe-
cific previous life challenges (e.g. combat, death of a
loved one, divorce, addiction or alcoholism) helped them
cope with their cancer. If Veterans identified some of
these experiences as beneficial, we asked them to openly
describe the ways these challenges helped them cope
with their illness.
At Time 2 we developed the “Health Values and Goals”
scale based on ours and others’ work [1,4,44]. This scale
measured how much impact a cancer diagnosis and treat-
ment had upon Veterans’ life goals and values. We asked
Veterans to first review a pre-determined list of life values
and/or goals that included, for example, taking care of my-
self (e.g. bathing, dressing), to walk or move around by my-
self, to avoid being a burden to others, and to make my
own life decisions (e.g. about health, finances, housing).
Veterans then chose from this list what they felt would be
their most important life value or goal and assigned a rating
of 10 (the highest rating meaning “I could not live without
this one”). Veterans were then asked to choose the life value
or goal of least importance and rate it numerically lower in
importance to all the others in the list. The remaining goals
and values were then rated between these two values; rat-
ings could be repeated. Upon completion of this rating,
Veterans were asked to reflect whether they achieved these
values and goals since their cancer diagnosis and treatment,
using a scale from 1 (I am not achieving this goal/value) to
5 (I am achieving this goal/value).
We concluded the Time 2 interview by asking Vet-
erans to think about their futures and respond to a series
of open-ended questions regarding this domain (“Now
that you have had cancer, and may face ongoing deci-
sions about medical care in the future, what would you
want your family, friends, and/or doctors to know about
you, in terms of what is most important to you in your
life?”“ If your cancer were to recur, is there anything you’d
want to be sure your loved ones knew about you and your
goals of care?”). To gather additional data on how to im-
prove cancer care services for Veterans, we again asked
Veterans to discuss what they felt the VA could improve
upon in the provision of cancer care (“What one thing
could the VA do better to support your cancer care
needs?”).
In addition to these measures, we also re-administered
the following scales from the Time 1 interview again at
Time 2 to measure any functional, social and psychological
changes in the past six months: BFS, PCL-C, VA CWADS
V1, PHQ 9, PROMIS 29, and the EORTC QLQ. We omit-
ted the cognitive and physical performance screening mea-
sures (MOCA, SPPB and grip strength) collected at Time 1
and chose to re-administer these measures again at Time 3
to avoid undue burden on the patient.
Time 3 interview (18 months)
The Time 3 interview asked Veterans to provide an up-
date on their illness narrative (“What is happening
you’re your cancer now?”) to document any changes in
their treatment experiences since the completion of their
Time 2 interview 6 months prior. We also asked Vet-
erans to reflect on how their life has changed for them
since being diagnosed with cancer 18 months ago with
the open-ended question, “From your perspective, what
has changed over the 18 months since you were diag-
nosed?” We asked Veterans again whether they were re-
ceiving treatment at that time, the date their treatment
ended, as well as how they conceptualized their progno-
sis (e.g. active, relapse, remission, cure, not sure and
other). Additionally, this interview included a set of
questions asking Veterans whether they had to make a
medical decision to continue or re-start their cancer
treatment after their initial treatment phase. If so, we
asked what that medical decision was, and the factors in-
volved in the Veterans’ decision-making process.
A tobacco assessment drawn from the Smoking History
and the Fagerstrom Tolerance Questionnaires [45] was
added to this interview. We asked Veterans if they cur-
rently smoked, and if so, to recall the number of cigarettes
they smoked per day over the last seven days. Besides ciga-
rettes, Veterans were also asked if they smoked cigars or
pipes, or use smokeless tobacco. In addition to the tobacco
assessment, alcohol usage was measured using the Alcohol
Use Disorders Identification Test (AUDIT) which focused
on the frequency of alcohol consumption (e.g. number of
alcoholic beverages consumed on an average day). Add-
itionally, we included Health Literacy Screening Questions
[46] as part of this interview protocol to assess the level of
difficulty Veterans may have had in understanding written
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vided to patients and medical forms.
We also included a series of open-ended questions at
Time 3 that asked Veterans to reflect upon their entire
cancer experience from diagnosis to 18 months. Vet-
erans described the most difficult aspect(s) of their ill-
ness experience (“In thinking about your whole cancer
experience, what has been the hardest part of having
cancer?”), what they believed will cause them the most
struggle in the future (“In thinking about the future of
dealing with this illness, what is the hardest thing for
you to face?”), and what they believed helped them cope
with their cancer (“What helped you the most in facing
the diagnosis and treatment of, and recovery from can-
cer?”). We again asked Veterans for their thoughts and
opinions on how the VA could improve cancer survivor-
ship health services.
In addition to the measures described above, we re-
assessed the following measures and scales from the
Time 1 and 2 interviews: MoCA, SPPB, grip strength,
PCL-C, VA CWADS V1, PHQ 9, Promise 29, EORTC
QLQ, PART, adapted IIRS, BFS well as the Treatment
Impact Scale.
Analyses
The longitudinal study design allowed for continuous
data analysis as study modules were completed and the
completeness of data verified. Analyses include: quanti-
tative analyses on item endorsement (yes/no) frequency,
item mean and total scale score mean and range for cog-
nition, physical capacity, cancer PTSD, worry, depres-
sion, quality of life, illness intrusiveness, and sexual
function, and qualitative analyses of diagnostic and treat-
ment experiences and meaning-making. Upon comple-
tion of our data collection, we will conduct quantitative
analyses comparing our measures across the 6, 12 and
18 month time points to test our hypotheses. To deter-
mine the longitudinal course of functional disability and
psychological distress in Veterans treated for cancer
(specific aim 1) we will evaluate multivariate models in
the form of multiple regressions. Path analysis will be
constructed to adjust these assessments of longitudinal
changes using groups of covariates (disease and treat-
ment variables; demographic variables; social support;
and pre-existing mental health variables). We will con-
duct similar multivariate analyses to determine the im-
pact of disability and distress on community integration
in Veterans treated for cancer, and the variables that me-
diate this relationship (specific aim 2).
To characterize gaps in Veterans Health Administra-
tion (VHA) rehabilitative services for Veterans following
cancer (specific aim 3) we will calculate means and item
frequencies for medical, emotional and educational care,
and obstacles to receiving health care services. We will
conduct mean and standard deviations to determine
Veterans’ interests in support services such as mental
health, CAM, rehabilitation and educational services.
Additionally, we will calculate bivariate correlations
comparing whether Veterans with mental health issues
are interested in mental health care and if those with
functional limitations will be interested in rehabilitative
and CAM services. To characterize patient-centered
goals for rehabilitation, community integration, and can-
cer survivorship treatment planning for Veterans follow-
ing cancer (specific aim 4) we will calculate item
frequencies for patient-centered goals. We will conduct
qualitative analyses on the open-ended responses using
both inductive and deductive coding methodologies de-
veloping at least an 80% inter-rater consistency rating.
We will then compare the coded open-ended results
with the closed ended ratings.
Discussion
The VetCaReS project team is led by principal investiga-
tors with backgrounds in clinical psychology and
internal medicine, both specialists in gerontology/geriat-
rics. Additional team members are drawn from diverse
disciplines in the behavioral and social sciences (clinical
and social psychology and anthropology) bringing a
breadth of theoretical and analytical expertise to the
study. Each week members of this multidisciplinary team
participated in a teleconference between the Boston and
Houston VA research sites to discuss a variety of oper-
ational issues associated with the study such as adminis-
trative tasks, recruitment, data collection, analyses, and
dissemination of study results.
An administrative meeting agenda is circulated among
team members, providing an overview of issues to discuss.
Detailed recruitment reports, compiled and updated by
the project coordinators, are discussed during these
weekly calls. These reports note the interview module
(Time 1, Time 2 and Time 3) and research site (Boston or
Houston VAMCs), the number of expected interviews for
a given month, followed by a detailed reporting of the
number of Veterans contacted for an interview (those
called and consenting to be interviewed, those called and
refusing to be interviewed, and the number of Veterans
mailed recruitment letters). The total number of inter-
views completed for each module and site, the number of
Veterans remaining to be interviewed, the final number of
overall valid interviews, and site totals were also included
on these reports.
These weekly meetings also included detailed case
study reports of recently completed interviews followed
by a discussion of the case among team members. These
case study reports provided a summary of the Veterans’
age, combat status, cancer type, stage, treatments, and
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sponses across instruments and other factors that may
complicate the Veterans case (e.g. stroke). Interviewers
also provided their thoughts on what was “most interest-
ing or significant about this interview,” if applicable,
how the VA “could better help this Veteran,” and if ap-
plicable, the reasons the Veteran “has been able to cope.”
The purpose of these case discussions was twofold. First,
project principal (JM) and co-principal (AN) investiga-
tors could hear from interviewers on the technical as-
pects of the research process which might affect the
validity of the data. Early on in the research process, we
were able to identify what newly added or open-ended
/non-standardized questions as well as response categor-
ies were working well, and those that required revision.
Second, these discussions also provided study team
members not directly involved in the data collection
process the opportunity to be introduced to the Veterans
and hear their stories. While interviewers were able to
interact with the Veterans directly and develop rapport,
the presentation of these case studies enabled other
members of the study team to understand responses to
standardized surveys that reflect the individual more
fully. Many of these case study discussions brought to
light relevant issues specific to this study population,
pathways for future analyses, as well as dialogue on the
more reflexive aspects of the research process itself.
Highlights from these team discussions are discussed
below:
 Stoma Reversal: We discussed the case of a veteran
in his 60s diagnosed with Stage III colorectal cancer,
and treated with surgery, which included a stoma,
and chemotherapy. This patient experienced
treatment related physical and emotional problems
including pain, fatigue, weakness, eating and
memory issues, as well as depression and difficulty
sleeping. The patient’s ongoing struggle with his
stoma has negatively impacted his quality of life, and
his reversal has been delayed due to other necessary
surgeries. We discussed the psychological impact for
Veterans of a delayed stoma reversal, and discussed
how the patient’s personal goals have been
integrated into his post-surgical care.
 Teeth and Dentures: Some Veterans underwent
prophylactic removal of all teeth in advance of
radiation therapy. Our interviews revealed that not
only did the loss of their teeth negatively affect their
quality of life, but they faced numerous difficulties
receiving dental care and, at-times, dentures. We felt
additional questions were needed in our interview
protocols to address this issue, and we also
addressed the issue through consultation at local
and national levels.
 Treatment Refusal: In the process of conducting this
study, the issue regarding treatment refusal arose.
There were a small number of Veterans (n =6) who
had their initial treatment, but refused further
intervention, while two refused treatment altogether
(n =2). We discussed the possibility of creating
separate variables to compare the Veterans who
opted for all their treatment to those who refused
some portions of treatment. Given the study’s
purpose of capturing both diagnostic and treatment
experiences, we reached consensus to remove the
two “refusal” patients and place them in a separate
database for future analysis. The discovery of this
subset of Veterans in the data set led us to consider
examining Veterans’ reasons behind their medical
decision to refuse all or some portion of their
treatment protocol.
 Challenges of the Interview Process: Weekly case
discussions not only provided interviewers the
opportunity to debrief the study team, but to discuss
the personal impact of the interview process. These
discussions revealed how developing a rapport with
these Veterans, many whom interviewers had been
interacting with for a year, caused mixed emotions.
While it gave interviewers a good feeling to close
their last interview seeing Veterans on the road to
recovery, it was difficult to see those Veterans who
were still struggling to regain their health 18 months
after their initial diagnosis.
 Post-Traumatic Growth: Our case discussions
revealed that not all Veterans conceptualized cancer
as a negative life experience, but rather as an
experience that brought post-traumatic growth. For
example, a white male in his 50s diagnosed with
Stage II colorectal cancer and treated with surgery
described feeling “totally shocked” when he was
diagnosed, and “was white as a ghost when they [the
doctors] told me.” He experienced depression and
“no support” from his ex-wife at this time. However,
he has since changed his outlook on life. He reports
being much happier, changed his diet to eat more
healthfully, and is now a practicing Buddhist. He
also reported disengaging from negative social
relationships that he felt were pulling him down
psychologically. Although he does fear recurrence,
he does not let that fear overrule his life.
In addition to these case study reports, study team
meetings included updates on current data checks. As
each study module (Time 1, Time 2, and Time 3) was
closed, the completeness of the data set was verified for
each site. The study team was also updated on the pro-
gress of the Medical Record Review (MRR) conducted to
verify the self-reported medical information provided by
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yearly renewals) as well as funding issues (e.g. participant
payments) were also reported during these meetings.
Weekly meetings also facilitated ongoing discussions re-
garding the dissemination of research results. Results in
the form of proposed and completed data analyses, confer-
ence presentations as well as publications were shared in
this diverse, multidisciplinary environment where team
members provided constructive feedback.
Conclusions
There is currently a lack of cancer survivorship research
focusing on aging Veterans. Therefore, the purpose of
this study was to document the functional, psychosocial
effects, and quality-of-life changes related to cancer
diagnosis and treatment from time of diagnosis to 18 -
months for aging Veterans, and to identify the unique
survivorship needs of this population. We anticipate that
results from this study will support some of our hypoth-
eses, and provide new knowledge to the wider literature
on cancer survivorship by revealing a greater under-
standing of this experience from the perspective of aging
Veterans as well as identify areas for future survivorship
interventions. Our study is innovative given the scope
and diversity of measures utilized within a longitudinal
study design, allowing us to document any functional
and psychosocial changes over time. Additionally, our
weekly teleconferences illustrate the iterative nature of
our research, allowing for refinement of study tools and
highlighting important issues for discussion, analyses
and further investigation. We anticipate that results
from this study will be useful in designing intervention
tools to improve the cancer survivorship experience for
aging Veterans.
Additional files
Additional file 1: International Statistical Classification of Diseases
and Related Health Problems (ICD-9) Codes for Cancers included in
the study. ICD-9 Codes utilized in the screening and recruitment
process.
Additional file 2: Meaning Making: Time 2 Interview. Questions
intending to ask about how the individual makes sense of the cancer
experience and copes with it.
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